Medicus Pharma Ltd. Common Stock
MDCX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,528 | $194 | $646 | $1,183 |
| G&A Expenses | $0 | $2,465 | $332 | $258 |
| SG&A Expenses | $7,653 | $2,465 | $332 | $258 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $2,072 | $0 | $0 |
| Operating Expenses | $11,181 | $4,730 | $978 | $1,441 |
| Operating Income | -$11,181 | -$4,730 | -$978 | -$1,441 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $25 | -$585 | -$714 | -$614 |
| Pre-Tax Income | -$11,156 | -$5,315 | -$1,692 | -$2,055 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11,156 | -$5,315 | -$1,692 | -$2,055 |
| % Margin | – | – | – | – |
| EPS | -1.1 | -1.53 | -0.88 | -0.26 |
| % Growth | 28.1% | -73.9% | -238.5% | – |
| EPS Diluted | -1.1 | -1.53 | -0.21 | -0.26 |
| Weighted Avg Shares Out | 9,619 | 3,479 | 1,930 | 8,049 |
| Weighted Avg Shares Out Dil | 9,619 | 3,479 | 8,049 | 8,049 |
| Supplemental Information | – | – | – | – |
| Interest Income | $104 | $11 | -$575 | -$575 |
| Interest Expense | $318 | $596 | $527 | $115 |
| Depreciation & Amortization | $0 | $2,072 | $0 | $0 |
| EBITDA | -$11,156 | -$587 | -$1,166 | -$1,940 |
| % Margin | – | – | – | – |